ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy

Yang, Mao; Xi, Ningning; Gao, Meng; Yu, Yanwei*哈尔滨医科大学
Bioengineered2022-5-2DOI: 10.1080/21655979.2022.2074109
7被引7阅读
引用收藏
分享

摘要

Potential ischemia/reperfusion (I/R) injuries are commonly induced during treatment of cardiovascular diseases, such as acute myocardial infarction (AMI). It is reported that oxidative stress and over-autophagy in cardiomyocytes are involved in the pathogenesis of I/R injury. Sitagliptin is an effective inhibitor of dipeptidyl peptidase 4 (DPP-4) for the treatment of diabetes, which is recently reported to regulate oxidative stress and autophagy. The present study is designed to explore the function of Sitagliptin on I/R injury. Hypoxia/reoxygenation (H/R) condition was used to simulate the I/R injury on cardiomyocytes. We found that the declined cell viability and elevated expression level of creatine kinase myocardial band (CK-MB) were observed in the H/R group, accompanied by the increased mitochondrial reactive oxygen species (ROS), elevated cellular malondialdehyde (MDA) level, and mitochondrial dysfunction. After Sitagliptin treatment, the damages in H9c2 cardiomyocytes, oxidative stress, and mitochondrial dysfunction were significantly alleviated. In addition, the overactivated autophagy and mitophagy in H/R-challenged cardiomyocytes were dramatically mitigated by Sitagliptin, accompanied by the upregulation of SIRT3. Lastly, the protective effect of Sitagliptin on H/R-induced mitophagy, autophagy, and damages in cardiomyocytes was dramatically abolished by the knockdown of SIRT3. Taken together, our data reveal that Sitagliptin ameliorated the H/R-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy.

学科与关键词

关键词
Sitagliptinischemiareperfusion injuryautophagySIRT3
相关
加载中…
  • Daming capsule protects against myocardial infarction by promoting mitophagy via the SIRT1/AMPK signaling pathway
    Sun, Xi; Han, Yanna; Dong, Chaorun; Qu, Huan; Yu, Yahan; Ju, Jiaming; Bai, Yunlong*; Yang, Baofeng*Biomedicine and Pharmacotherapy, 2022, 151: 113162.被引 4
  • DPP-4 inhibitor anagliptin protects against hypoxia-induced cytotoxicity in cardiac H9C2 cells
    Ma, Yunxiang; Wang, Junkai; Wang, Changhua; Zhang, Qiong; Xu, Yannan; Liu, Huajin; Xiang, Xia*; Ma, Jiangwei*Artificial Cells Nanomedicine and Biotechnology, 2019, 47(1): 3823-3831.
  • Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway
    Zhou, Gang; Wu, Hui*; Yang, Jian; Ye, Ming; Liu, Di; Li, Yunzhao; Zhang, Dong; Zhang, Jing; Yang, Qingzhuo; Liu, YanfangCardiovascular Toxicology, 2023, 23(3-4): 161-175.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Bioengineered
发表日期
2022-05-02
卷期
第 13 卷, 第 5 期
页码
13162-13173
DOI
10.1080/21655979.2022.2074109
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
Post-doctoral research start-up fund of Heilongjiang Province [LBH-Q19153]

作者

  • Y

    Yang, Mao (第一作者)

    harbin med univ

  • X

    Xi, Ningning

    heilongjiang univ tradit chinese med

查看全部 4 位作者收起作者
  • G

    Gao, Meng

    harbin med univ

  • Y

    Yu, Yanwei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417